These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13705253)

  • 1. [Congenital adrenal hyperplasia with sodium chloride loss. Hormonal study. Metabolism of 11-desoxycortisol].
    GILBERT-DREYFUS ; FRANK J; SEBAOUN J; ROBEL J; DRAY F; ADAM Y; CHABOT A
    Ann Endocrinol (Paris); 1961; 22():100-9. PubMed ID: 13705253
    [No Abstract]   [Full Text] [Related]  

  • 2. [PRODUCTION OF ALDOSTERONE AND HYDROCORTISONE IN CHILDREN WITH CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFECT), WITH AND WITHOUT "SALT-LOSING" SYNDROME].
    VISSER HK; DEGENHART HJ; WILMINK R; CROUGHS W
    Ned Tijdschr Geneeskd; 1965 Jun; 109():1176-8. PubMed ID: 14320600
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies on the biosynthesis, secretion and metabolism of cortisol. II. The urinary excretions of tetrahydro-11-desoxycortisol, tetrahydrocortisone and tetrahydrocortisol in patients with congenital adrenal hyperplasia and Cushing's syndrome].
    Matsushita R
    Naika Hokan; 1967; 14(3):91-9. PubMed ID: 5624239
    [No Abstract]   [Full Text] [Related]  

  • 4. Salt-losers and non salt-losers in congenital adrenal hyperplasia.
    Bartter FC
    Arch Dis Child; 1969 Feb; 44(233):138-9. PubMed ID: 4303934
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of congenital adrenal hyperplasia with concentrated hydrocortisone acetate.
    LITMAN NN; DONNELL GN
    J Clin Endocrinol Metab; 1960 Jun; 20():862-8. PubMed ID: 14417518
    [No Abstract]   [Full Text] [Related]  

  • 6. Some effects of abnormalities of pituitary, adrenal or thyroid function on excretion of aldosterone and the response to corticotropin or sodium deprivation.
    LIEBERMAN AH; LUETSCHER JA
    J Clin Endocrinol Metab; 1960 Jul; 20():1004-16. PubMed ID: 14416830
    [No Abstract]   [Full Text] [Related]  

  • 7. [Physiopathology of the salt-losing syndrome during congenital adrenal hyperplasia related to a 21-hydroxylation defect].
    Rappaport R
    Ann Pediatr (Paris); 1965 Dec; 12(12):807-8. PubMed ID: 5854043
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistent testicular delta5-isomerase-3beta-hydroxysteroid dehydrogenase (delta5-3beta-HSD) deficiency in the delta5-3beta-HSD form of congenital adrenal hyperplasia.
    Schneider G; Genel M; Bongiovanni AM; Goldman AS; Rosenfield RL
    J Clin Invest; 1975 Apr; 55(4):681-90. PubMed ID: 164481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid therapy in the neonatal period.
    Klevit HD
    Pediatr Clin North Am; 1970 Nov; 17(4):1003-13. PubMed ID: 5530741
    [No Abstract]   [Full Text] [Related]  

  • 10. [Salt wasting syndrome caused by congenital, insufficient synthesis or aldosterone function--etiology, diagnosis and management].
    Basiak A; Wikiera B; Noczyńska A
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(2):103-8. PubMed ID: 15996340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Excretion of labile acid aldosterone in congenital adrenal hypertrophy].
    Dahl V; Bergadá C
    Rev Argent Endocrinol Metab; 1969 Mar; 15(1):9-16. PubMed ID: 5404550
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of the level of production of cortisol, corticosterone, aldosterone and deoxycorticosterone in 4 cases of congenital adrenal hyperplasia due to II beta-hydroxylase deficiency.
    Loras B; Dazord A; Roux H; Bertrand J
    Rev Eur Etud Clin Biol; 1971; 16(6):585-90. PubMed ID: 5125107
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cortisol metabolism in postnatal adrenal hyperplasia].
    PINSKER P; HORAK M; BULTASOVA H; HORNACEK J
    Cesk Fysiol; 1959 Apr; 8(3):234. PubMed ID: 13671573
    [No Abstract]   [Full Text] [Related]  

  • 14. Salt-losing in an infant with congenital adrenal hyperplasia and normal aldosterone production.
    Visser HK; Degenhart HJ
    Acta Paediatr Scand; 1967 Mar; 56(2):216-20. PubMed ID: 6049804
    [No Abstract]   [Full Text] [Related]  

  • 15. A new form of congenital adrenal hyperplasia.
    New MI; Peterson RE
    J Clin Endocrinol Metab; 1967 Feb; 27(2):300-5. PubMed ID: 6018580
    [No Abstract]   [Full Text] [Related]  

  • 16. Steroid metabolism in a case of congenital adrenal hyperplasia.
    COPE CL
    Br Med J; 1959 Mar; 1(5125):815-7. PubMed ID: 13629129
    [No Abstract]   [Full Text] [Related]  

  • 17. Adrenal insufficiency in two male infants.
    Rossiter MA; Eades SM; Brimblecombe FS
    Proc R Soc Med; 1970 May; 63(5):488-9. PubMed ID: 4318214
    [No Abstract]   [Full Text] [Related]  

  • 18. Further evidence of a relative lack of C-21 hydroxylation in congenital adrenal hyperplasia.
    FRANTZ AG; HOLUB DA; JAILER JW
    J Clin Invest; 1960 Jun; 39(6):904-8. PubMed ID: 13824597
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum magnesium level in the salt-losing type of congenital adrenal hyperplasia.
    Kobayashi A; Igarashi Y
    Arch Dis Child; 1968 Apr; 43(228):223-8. PubMed ID: 5645695
    [No Abstract]   [Full Text] [Related]  

  • 20. Renin, angiotensin, aldosterone and hormonal regulation of arterial pressure and salt balance. Introductory remarks.
    Laragh JH
    Fed Proc; 1967; 26(1):39-41. PubMed ID: 4289566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.